Anning Li

State Key Laboratory Of Digestive Health
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Efficacy of gut-brain neuromodulators in functional esophageal disorders: a systematic review.

Efficacy of gut-brain neuromodulators in functional esophageal disorders: a systematic review.

Journal: BMC gastroenterology

Published: May 23, 2026

Efficacy and safety of Dimdazenil in primary insomnia and depressive episodes/bipolar depressive episode with insomnia: A post-marketing, randomized, open-label, positive-controlled study.

Efficacy and safety of Dimdazenil in primary insomnia and depressive episodes/bipolar depressive episode with insomnia: A post-marketing, randomized, open-label, positive-controlled study.

Journal: Journal of affective disorders

Published: March 11, 2026

Trajectories of Perinatal Depressive Symptoms from the Second Trimester to Three Months Postpartum and Their Dynamic Relationship with Social Support: A Prospective Cohort Study in Beijing, China.

Trajectories of Perinatal Depressive Symptoms from the Second Trimester to Three Months Postpartum and Their Dynamic Relationship with Social Support: A Prospective Cohort Study in Beijing, China.

Journal: International journal of women's health

Published: November 30, 2025

ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression: The ENLIGHTEN Randomized Clinical Trial.

ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression: The ENLIGHTEN Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: September 10, 2025

Heterogeneity in perinatal depression and its related factors: a longitudinal study in Beijing, China.

Heterogeneity in perinatal depression and its related factors: a longitudinal study in Beijing, China.

Journal: Journal of affective disorders

Published: July 19, 2025

Evolution of drug classification, target distribution, and introduction of novel antidepressants in China.

Evolution of drug classification, target distribution, and introduction of novel antidepressants in China.

Journal: Science China. Life sciences

Published: June 02, 2025

Pilot randomized controlled trial of transcranial magnetic stimulation for the treatment of insomnia in cancer survivors: An efficacy, safety, and feasibility therapy.

Pilot randomized controlled trial of transcranial magnetic stimulation for the treatment of insomnia in cancer survivors: An efficacy, safety, and feasibility therapy.

Journal: International journal of cancer

Published: November 03, 2024

Healthy lifestyle and risk of incidence, mortality and life expectancy of mental disorders.

Healthy lifestyle and risk of incidence, mortality and life expectancy of mental disorders.

Journal: Journal of affective disorders

Published: August 29, 2024

Single- and multiple-dose pharmacokinetics, safety, and tolerability of Aripiprazole once-monthly, long-acting intramuscular injection for Chinese adults with schizophrenia.

Single- and multiple-dose pharmacokinetics, safety, and tolerability of Aripiprazole once-monthly, long-acting intramuscular injection for Chinese adults with schizophrenia.

Journal: BMC psychiatry

Published: May 30, 2024

Effectiveness and safety of aripiprazole oral solution in the acute treatment of schizophrenia in Chinese patients.

Effectiveness and safety of aripiprazole oral solution in the acute treatment of schizophrenia in Chinese patients.

Journal: BMC psychiatry

Published: March 06, 2024

Effect of transcranial direct current stimulation with concurrent cognitive performance targeting posterior parietal cortex vs prefrontal cortex on working memory in schizophrenia: a randomized clinical trial.

Effect of transcranial direct current stimulation with concurrent cognitive performance targeting posterior parietal cortex vs prefrontal cortex on working memory in schizophrenia: a randomized clinical trial.

Journal: Translational psychiatry

Published: January 15, 2024

Gamma-aminobutyric acid supplementation improves olanzapine-induced insulin resistance by inhibiting macrophage infiltration in mice subcutaneous adipose tissue.

Gamma-aminobutyric acid supplementation improves olanzapine-induced insulin resistance by inhibiting macrophage infiltration in mice subcutaneous adipose tissue.

Journal: Diabetes, obesity & metabolism

Published: November 17, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026